Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

Elektrosens

Financiado

Cerrado

Wearable Sweat based painless and continuous glucose monitoring device for diabe...

Wearable Sweat based painless and continuous glucose monitoring device for diabetic people There are 60 million people with diabetes in the EU (10% of total population). Diabetes is the major cause of death in the age of 20- 79. Also, Europe has the highest number of children with Type 1 diabetes (T1D) compared to other... ver más

30/04/2020

Elektrosens

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

ELEKTROSENS SAGLIK VE DANISMANLIK HIZMETLERI... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 10 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-04-30

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

10 Participantes

Elektrosens

50.00K€ | Lider

ANTOBAL

230.34K€ | Participante

AUTOMATISMOS Y ELECTROMECANI...

206.05K€ | Participante

FLEJES INDUSTRIALES

737.23K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

KWatch Glucose K Watch Glucose A ground breaking biometric wearable for pa... 71K€ Cerrado

SensCare AI-based wearable sensors for continuous monitoring of diabe... 75K€ Cerrado

Sencell16 Lifecare s Sencell sensor is an implantable micro sensor for... 71K€ Cerrado

DiaMOND personalised Diabetes Management using lOw cost Needle free... 5M€ Cerrado

K Watch Glucose KWatch Glucose A Wearable Painless Continuous Glucose Monit... 3M€ Cerrado

PDC2021-121470-C21 PREDICCION DE GLUCOSA SIN INTERVENCION DEL USUARIO PARA EL A... 69K€ Cerrado

Duración del proyecto: 4 meses Fecha Inicio: 2019-12-03
Fecha Fin: 2020-04-30

Líder del proyecto

ELEKTROSENS SAGLIK VE DANISMANLIK HIZMETLERI... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto There are 60 million people with diabetes in the EU (10% of total population). Diabetes is the major cause of death in the age of 20- 79. Also, Europe has the highest number of children with Type 1 diabetes (T1D) compared to other regions with approximately 140,000 diagnosed children and it has one of the highest prevalence rates of diabetes in children with 21,600 new cases per year. The frequent glucose monitoring is the key element in achieving good glycemic control which is the most important factor in preventing diabetes related complications such as diabetic retinopathy, kidney damage, heart disease, stroke and etc. Due to the high cost of the current CGM devices or pain associated with traditional finger-prick measurement, people cannot monitor their blood glucose level continuously. In 2015, 627,000 people aged between 20-79 died due to diabetes related complications. UK prospective study shows that continuous glucose monitoring leads to improved glycemic control, which in turn results in reduced diabetes related complications. Study shows that with continuous glucose monitoring diabetes related retinopathy and nephropathy (eye damage) in type 1 and type 2 diabetes decreased around 60% and microvascular complication rate decreased 25%. Elektrosens Wristband uses a highly selective and accurate novel polymer technology sensing very low sweat glucose levels which are correlated to blood glucose. Our innovative solution makes the continuous glucose monitoring affordable for all customer segments. The main objectives of this product can be divided into two groups; mainly providing a sustainable healthy lifestyle and reducing the economic burdens., we now aim to introduce our technology to diabetes devices market seeing how our solution offers significant performance improvements and is market disrupting in its potential. Our new prototype designed and built, is currently at TRL6 stage.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores